论文信息 - Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families. - 字舞流文

Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families.

S. Puig | D. Bishop | D. Elder | L. Cannon-Albright | G. Mann | N. Hayward | H. Olsson | M. Tucker | A. Goldstein | A. Pritchard | C. Ingvar | M. Hočevar | S. Leachman | J. Hansson | A. Gerdes | J. N. Newton Bishop | M. Harland | N. Gruis | W. Bergman | N. Mitra | M. Landi | E. Nagore | P. Kanetsky | K. Wadt | F. Demenais | B. Bressac-de Paillerets | M. Avril | V. Höiom | Xiaohong R. Yang | G. Landman | A. Cust | J. Palmer | P. Ghiorzo | E. Azizi | D. Calista | N. van der Stoep | W. Bruno | F. Cuéllar | L. Whitaker | B. Perić | K. Wadt | D. Pjanova | T. C. Grazziotin | N. Taylor | Alejandra Larre-Borges | D. E. Elder | Nicholas K. Hayward | Margaret A. Tucker | Lisa A. Cannon-Albright | Graham J. Mann | Maria Teresa Landi | Alisa M. Goldstein | A. E. Cust | D. Bishop | Xiaohong R. Yang

[1] David John Adams,et al. Melanoma: a global perspective , 2017, Nature Reviews Cancer.

[2] N. Gruis,et al. The absence of multiple atypical nevi in germline CDKN2A mutations: Comment on "Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome". , 2016, Journal of the American Academy of Dermatology.

[3] S. Puig,et al. Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma Families. , 2016, The Journal of investigative dermatology.

[4] H. Tsao,et al. Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome. , 2016, Journal of the American Academy of Dermatology.

[5] R. Dummer,et al. The Genetic Evolution of Melanoma from Precursor Lesions. , 2015, The New England journal of medicine.

[6] J. Malvehy,et al. Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia, Spain and the United Kingdom , 2014, Hereditary cancer in clinical practice.

[7] Jeffrey E. Lee,et al. Genome-wide association study identifies three new melanoma susceptibility loci , 2011, Nature Genetics.

[8] K. Nielsen,et al. Swedish CDKN2A mutation carriers do not present the atypical mole syndrome phenotype , 2010, Melanoma research.

[9] T. Spector,et al. Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi , 2009, Nature Genetics.

[10] E. Gillanders,et al. Genome-wide linkage scan for atypical nevi in p16-Leiden melanoma families , 2008, European Journal of Human Genetics.

[11] S. Puig,et al. A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL). , 2008, European journal of cancer.

[12] S. Puig,et al. Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents , 2006, Journal of Medical Genetics.

[13] J. Trent,et al. A genome-wide scan for naevus count: linkage to CDKN2A and to other chromosome regions , 2007, European Journal of Human Genetics.

[14] S. Puig,et al. High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. , 2006, Cancer research.

[15] T. Spector,et al. Genome-wide search for nevus density shows linkage to two melanoma loci on chromosome 9 and identifies a new QTL on 5q31 in an adult twin cohort. , 2006, Human molecular genetics.

[16] L. Cannon-Albright,et al. Longitudinal assessment of the nevus phenotype in a melanoma kindred. , 2004, The Journal of investigative dermatology.

[17] H. Lynch,et al. Characterization of the neoplastic phenotype in the familial atypical multiple‐mole melanoma–pancreatic carcinoma syndrome , 2003, Cancer.

[18] J. Barrett,et al. Linkage and association analysis of nevus density and the region containing the melanoma gene CDKN2A in UK twins , 2003, British Journal of Cancer.

[19] J. Barrett,et al. An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility allele. , 2002, The Journal of investigative dermatology.

[20] S. Kern,et al. Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma–pancreatic carcinoma–prone families , 2002, Cancer.

[21] M. Tucker,et al. Genetic epidemiology of cutaneous melanoma: a global perspective. , 2001, Archives of dermatology.

[22] J. Struewing,et al. Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations. , 2000, Journal of the National Cancer Institute.

[23] J. A. Bishop,et al. Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations. , 2000, The Journal of investigative dermatology.

[24] M. Tucker,et al. Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: A consensus statement of the Melanoma Genetics Consortium. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25] J F Aitken,et al. A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs. , 1999, American journal of human genetics.

[26] L. Sandkuijl,et al. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds , 1995, Nature Genetics.

[27] M. Skolnick,et al. Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM). , 1994, Cancer research.

[28] W. Clark,et al. Germline p16 mutations in familial melanoma , 1994, Nature Genetics.

[29] D. Bishop,et al. Family studies in melanoma: identification of the atypical mole syndrome (AMS) phenotype , 1994, Melanoma research.

[30] H. Lynch,et al. Familial atypical multiple mole-melanoma syndrome. , 1978, Journal of medical genetics.